Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line

Breast Cancer Research and Treatment

Volumn 12, Issue 2, 1988, Pages 213-225

  Poulin, Richard ^a   Baker, Denis ^a   Labrie, Fernand ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

androgen receptor; androgens; antiandrogen; antiestrogen; breast cancer; estrogen receptor

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; ANDROSTENEDIONE; ESTRADIOL; ESTROGEN RECEPTOR; HYDROXYFLUTAMIDE; METRIBOLONE; RALOXIFENE; TESTOSTERONE;

BREAST CANCER; CELL CULTURE; CELL GROWTH; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; TUMOR CELL LINE;

ANDROGEN ANTAGONISTS; ANDROSTENEDIONE; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN ANTAGONISTS; FLUTAMIDE; HUMAN; PIPERIDINES; RALOXIFENE; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; STANOLONE; SUPPORT, NON-U.S. GOV'T; TESTOSTERONE;

EID: 0024264118     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/BF01805942     Document Type: Article

References (60)

1. Treatment of breast cancer with testosterone propionate. A preliminary report
2. Hormonal therapy in cancer of the breast. 1. The effect of testosterone propionate therapy on clinical course and hormonal excretion
3. Testosterone propionate therapy of breast cancer
4. Fluoxymesterone therapy in treatment of advanced breast cancer
5. Evaluation of Tamoxifen doses with and without fluoxymesterone in advanced breast cancer
6. Calusterone (7β,17α-dimethyltestosterone) as primary and secondary therapy of advanced breast cancer
7. Anabolic-androgenic steroids
8. The use of androgens in the treatment of neoplastic disease
9. Estrogen receptors in human breast cancer: an overview
10. Steroid binding proteins in normal and neoplastic mammary cells
11. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer
12. Steroid receptor analyses of nine human breast cancer cell lines
13. The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture
14. A secreted glycoprotein induced by estrogen in human breast cancer cell lines
15. Human breast cancer: androgen action mediated by estrogen receptor
16. Androgen action through estrogen receptor in a human breast cancer cell line
17. An antiestrogenic action of androgens in human breast cancer cells
18. Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletion
19. Identification and androgen regulation of two proteins released by T47D human breast cancer cells
20. Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP)
21. In vitro modulation of prolactin binding to human mammary carcinoma cells by steroid hormones and prolactin
22. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas
23. Antiandrogenicity of flutamide and its metabolite Sch16423
24. Characteristics of interaction of the antiandrogen Flutamide with the androgen receptor in various target tissues
25. Effects of a new antiestrogen, keoxifene (LY156758), on growth of car-cinogen-induced mammary tumors and on LH and prolactin levels
26. Keoxifene shows pure antiestrogenic activity in pituitary gonadotrophs
27. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture
28. Estrogenic activity of phenol red in rat anterior pituitary cells in culture
29. Stimulation of cell proliferation and estrogenic response by adrenal C19-Δ5-steroids in the ZR-75-1 human breast cancer cell line
30. A simple method to determine whole cell uptake of radiolabeled oestrogens and progesterone and their subcellular localization in breast cancer cell lines in monolayer cultures
31. The attraction of proteins for small molecules and ions
32. Apparent positive cooperative effect in cyclic AMP and corticosterone production by related adrenal cells in response to ACTH analogs
33. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction
34. Extension of multiple-range test to group means with unique numbers of replications
35. The estrogenic and antiestrogenic activities of androgens in female target tissues
36. Androgen on the oestrogen receptor: II. Correlation between nuclear translocation and uterine protein synthesis
37. Chemical structure of steroids in relation to promotion of growth of the vagina and uterus of the hypophysectomized rat
38. Anabolic-androgenic steroids and experimental mammary tumors
39. Androgen effects mediated by estrogen receptor in 7,12-dimethylbenz(a)anthracene-in-duced rat mammary tumors
40. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture
41. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells
42. Receptor binding as a tool in the development of selective new bioactive steroids and nonsteroids
43. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle
44. Factors affecting sex hormone levels in postmenopausal women
45. Endogenous C19-steroids and estradiol levels in human primary breast tumor tissues and their correlation with androgen and estrogen receptors
46. The specific binding of androgens and the subsequent distribution of androgen receptor complexes within MCF-7 human breast cancer cells
47. The relationship between growth and androstenedione metabolism in four cell lines of human breast carcinoma cells in culture
48. Transformation of steroids by mammary cancer tissue
49. The metabolism of androstenedione and testosterone to C19-metabolites in normal breast, breast carcinoma, and benign prostatic hypertrophy tissue
50. Androgen control of cytosol progesterone receptor levels in the MT-W9B transplantable mammary tumor in the rat
51. Androgen receptor-mediated inhibition of estrogen-induced uterine peroxidase
52. Estrogen-induced progesterone receptor in the Syrian hamster kidney. I. Modulation by antiestrogens and androgens
53. Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells. Mechanism of antagonism by testosterone
54. Estrogen downregulation of androgen receptors in cultured human mammary cancer cells (MCF-7)
55. Estrogen-receptor mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen
56. Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells
57. Prolonged retention of estradiol by human breast cancer cells in tissue culture
58. Rapid induction of mammary carcinoma in the rat and the influence of hormone on the tumors
59. Growth and therapy of mammary tumors induced by 7,12-dimethylbenz(a)anthracene in rats
60. The structure and function of progesterone receptors in breast cancer